Spero Therapeutics Inc

2HA

Company Profile

  • Business description

    Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

  • Contact

    675 Massachusetts Avenue
    14th Floor
    CambridgeMA02139
    USA

    T: +1 857 242-1600

    E: [email protected]

    https://www.sperotherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    32

Stocks News & Analysis

stocks

Ask the analyst: Can this genius product create the next ASX software king?

SiteMinder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.
stocks

Impact of ANZ’s huge fine

Working to prevent repeated failures could also improve competitiveness.
stocks

Acquisition a sign of weakness for overvalued ASX share

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,094.9027.60-0.30%
CAC 407,809.029.20-0.12%
DAX 4023,426.2897.040.42%
Dow JONES (US)46,017.53259.630.57%
FTSE 1009,242.7747.110.51%
HKSE26,908.39469.881.78%
NASDAQ22,262.9071.06-0.32%
Nikkei 22544,790.38111.89-0.25%
NZX 50 Index13,228.386.51-0.05%
S&P 5006,603.653.11-0.05%
S&P/ASX 2008,818.5030.00-0.34%
SSE Composite Index3,876.3414.480.37%

Market Movers